Drug Profile
Recombinant erythropoietin biosimilar - Lupin
Alternative Names: Epocept; Erythropoietin biosimilar - Lupin; rHuEPO biosimilar - LupinLatest Information Update: 08 May 2014
Price :
$50
*
At a glance
- Originator Lupin
- Class Antianaemics; Polyethylene glycols; Recombinant erythropoietins; Recombinant fusion proteins
- Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Anaemia
Most Recent Events
- 07 May 2014 Launched for Anaemia (in adult patients with chronic renal failure) in India (IV) before May 2014
- 07 May 2014 Launched for Anaemia (in adult patients with chronic renal failure) in India (SC) before May 2014
- 17 Aug 2011 Registered for Anaemia (in adult patients with chronic renal failure) in India (IV)